Neuroprotection by glucagon: Role of gluconeogenesis. Laboratory investigation

Journal of Neurosurgery

Volumn 114, Issue 1, 2011, Pages 85-91

  Abu Fanne, Rami ^a,d   Nassar, Taher ^a   Mazuz, Achinoam ^b   Waked, Otailah ^a   Heyman, Samuel N ^b   Hijazi, Nuha ^a   Goelman, Gadi ^b   Higazi, Abd Al Roof ^a,c  

^a Human Biology Research Center   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Glucagon; Neuroprotection; Traumatic brain injury

Indexed keywords

GLUCAGON; GLUTAMIC ACID; INSULIN;

ADOLESCENT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DRUG MECHANISM; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HEAD INJURY; HISTOLOGY; LIVER METABOLISM; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; GLUCAGON; GLUCONEOGENESIS; GLUCOSE; GLUTAMATES; HEAD INJURIES, CLOSED; INJECTIONS, INTRAPERITONEAL; LIVER; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; NEUROPROTECTIVE AGENTS;

EID: 78651294475     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.4.JNS10263     Document Type: Article

References (36)

1. Alsop DC, Murai H, Detre JA, McIntosh TK, Smith DH: Detection of acute pathologic changes following experimental traumatic brain injury using diffusion-weighted magnetic resonance imaging. J Neurotrauma 13:515-521, 1996
2. Bendotti C, Tortarolo M, Suchak SK, Calvaresi N, Carvelli L, Bastone A, et al: Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem 79:737-746, 2001
3. Beni-Adani L, Gozes I, Cohen Y, Assaf Y, Steingart RA, Brenneman DE, et al: A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J Pharmacol Exp Ther 296:57-63, 2001 (Pubitemid 32015060)
4. Bilotta F, Caramia R, Cernak I, Paoloni FP, Doronzio A, Cuzzone V, et al: Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocrit Care 9:159-166, 2008
5. Brockman RP, Bergman EN, Joo PK, Manns JG: Effects of glucagon and insulin on net hepatic metabolism of glucose precursors in sheep. Am J Physiol 229:1344-1349, 1975
6. Chen Y, Constantini S, Trembovler V, Weinstock M, Shohami E: An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J Neurotrauma 13:557-568, 1996
7. Dahl NA, Balfour WM: Prolonged anoxic survival due to anoxia pre-exposure: brain ATP, lactate, and pyruvate. Am J Physiol 207:452-456, 1964
8. Davis LM, Pauly JR, Readnower RD, Rho JM, Sullivan PG: Fasting is neuroprotective following traumatic brain injury. J Neurosci Res 86:1812-1822, 2008
9. Faden AI, Demediuk P, Panter SS, Vink R: The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244:798-800, 1989
10. Fujiwara T, Cherrington AD, Neal DN, McGuinness OP: Role of cortisol in the metabolic response to stress hormone infusion in the conscious dog. Metabolism 45:571-578, 1996
11. Gottlieb M, Wang Y, Teichberg VI: Blood-mediated scavenging of cerebrospinal fluid glutamate. J Neurochem 87:119-126, 2003
12. Griesdale DE, Tremblay MH, McEwen J, Chittock DR: Glucose control and mortality in patients with severe traumatic brain injury. Neurocrit Care [epub ahead of print], 2009
13. Hu ZG, Wang HD, Qiao L, Yan W, Tan QF, Yin HX: The protective effect of the ketogenic diet on traumatic brain injury-induced cell death in juvenile rats. Brain Inj 23:459-465, 2009
14. Ito J, Marmarou A, Barzó P, Fatouros P, Corwin F: Characterization of edema by diffusion-weighted imaging in experimental traumatic brain injury. J Neurosurg 84:97-103, 1996 (Pubitemid 26007003)
15. Lipton SA: Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov 5:160-170, 2006
16. Liu-DeRyke X, Collingridge DS, Orme J, Roller D, Zurasky J, Rhoney DH: Clinical impact of early hyperglycemia during acute phase of traumatic brain injury. Neurocrit Care 11: 151-157, 2009
17. Luck JM, Morrison G, Wilbur LF: The effect of insulin on the amino acid content of blood. J Biol Chem 77:151-156, 1928
18. Martínez ML, Landry C, Boehm R, Manning S, Cheek AO, Rees BB: Effects of long-term hypoxia on enzymes of carbohydrate metabolism in the Gulf killifish, Fundulus grandis. J Exp Biol 209:3851-3861, 2006 (Pubitemid 44682348)
19. McGuinness OP, Fujiwara T, Murrell S, Bracy D, Neal D, O'Connor D, et al: Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. Am J Physiol 265:E314-E322, 1993
20. Nelson D, Cox M: Gluconeogenesis, in Lehninger AL (ed): Principles of Biochemistry, ed 4. New York: WH Freeman, 2005, pp 543-549
21. Rao VL, Dogan A, Todd KG, Bowen KK, Dempsey RJ: Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats. Brain Res 911:96-100, 2001
22. Salim A, Hadjizacharia P, Dubose J, Brown C, Inaba K, Chan LS, et al: Persistent hyperglycemia in severe traumatic brain injury: an independent predictor of outcome. Am Surg 75:25-29, 2009
23. Schaefer PW, Grant PE, Gonzalez RG: Diffusion-weighted MR imaging of the brain. Radiology 217:331-345, 2000
24. Schurr A, Reid KH, Tseng MT, West C, Rigor BM: Adaptation of adult brain tissue to anoxia and hypoxia in vitro. Brain Res 374:244-248, 1986
25. Selim M: Perioperative stroke. N Engl J Med 356:706-713, 2007
26. Sevick RJ, Kanda F, Mintorovitch J, Arieff AI, Kucharczyk J, Tsuruda JS, et al: Cytotoxic brain edema: assessment with diffusion-weighted MR imaging. Radiology 185:687-690, 1992
27. Shapira Y, Shohami E, Sidi A, Soffer D, Freeman S, Cotev S: Experimental closed head injury in rats: mechanical, pathophysiologic, and neurologic properties. Crit Care Med 16:258-265, 1988
28. Steiger HJ, Hänggi D: Ischaemic preconditioning of the brain, mechanisms and applications. Acta Neurochir (Wien) 149:1-10, 2007
29. Teichberg VI, Cohen-Kashi-Malina K, Cooper I, Zlotnik A: Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies. Neuroscience 158:301-308, 2009
30. Van Putten HP, Bouwhuis MG, Muizelaar JP, Lyeth BG, Berman RF: Diffusion-weighted imaging of edema following traumatic brain injury in rats: effects of secondary hypoxia. J Neurotrauma 22:857-872, 2005 (Pubitemid 41153871)
31. Wasserman DH, Spalding JA, Lacy DB, Colburn CA, Goldstein RE, Cherrington AD: Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. Am J Physiol 257:E108-E117, 1989
32. Wright PA, Perry SF, Moon TW: Regulation of hepatic gluconeogenesis and glycogenolysis by catecholamines in rainbow trout during environmental hypoxia. J Exp Biol 147:169-188, 1989
33. Yamamoto T, Rossi S, Stiefel M, Doppenberg E, Zauner A, Bullock R, et al: CSF and ECF glutamate concentrations in head injured patients. Acta Neurochir Suppl 75:17-19, 1999
34. Yellon DM, Dana A: The preconditioning phenomenon: a tool for the scientist or a clinical reality? Circ Res 87:543-550, 2000
35. Zhang H, Zhang X, Zhang T, Chen L: Excitatory amino acids in cerebrospinal fluid of patients with acute head injuries. Clin Chem 47:1458-1462, 2001
36. Zlotnik A, Gurevich B, Tkachov S, Maoz I, Shapira Y, Teichberg VI: Brain neuroprotection by scavenging blood glutamate. Exp Neurol 203:213-220, 2007